PAUL SCHIMMEL

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PAUL SCHIMMEL:

Company Role Class Num Shares Value Price $ Report Date Ownership
aTYR PHARMA INC Director Common Stock 1,413,023 $7,432,500 $5.26 09 Oct 2025 Indirect
aTYR PHARMA INC Director Common Stock 8,890 $46,761 $5.26 08 Oct 2025 Direct
aTYR PHARMA INC Director Stock Option (right to buy) 50,000 01 May 2025 Direct

Insider Reports Filed by PAUL SCHIMMEL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATYR aTYR PHARMA INC 08 Oct 2025 2 +$911,801 4 Director 09 Oct 2025, 18:30
ATYR aTYR PHARMA INC 01 May 2025 1 $0 4 Director 02 May 2025, 17:23
ATYR aTYR PHARMA INC 22 Jul 2024 3 +$184,613 4 Director 24 Jul 2024, 17:29
ATYR aTYR PHARMA INC 22 May 2024 1 $0 4 Director 23 May 2024, 19:16
ATYR aTYR PHARMA INC 17 May 2023 1 $0 4 Director 19 May 2023, 16:32
ATYR aTYR PHARMA INC 10 May 2023 1 +$450,000 4 Director 11 May 2023, 09:00
ATYR aTYR PHARMA INC 26 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:54
ATYR aTYR PHARMA INC 26 Apr 2022 1 $0 4 Director 28 Apr 2022, 19:53
ATYR aTYR PHARMA INC 20 Sep 2021 3 +$2,000,000 4 Director 22 Sep 2021, 20:19
ATYR aTYR PHARMA INC 18 May 2021 1 +$199,000 4 Director 20 May 2021, 08:55